Abstract
Cardiogenic shock (CS) is a severe and frequent complication of acute myocardial infarction (AMI), necessitating rapid and accurate prognosis as-sessment to guide treatment and intensive care unit (ICU) resource allocation. We developed two machine learning models to predict 30-day outcomes following CS in AMI: an Admission model (using only data available at admission, like demography, comorbidities) and a Full model (incorporating additional laboratory values obtained within 24 hours). The models were trained on the CULPRIT-SHOCK dataset and externally validated using the eICU database. The Admission model achieved an out-of-sample AUC of 0.71 (95% CI: 0.6–0.83) in the development cohort and 0.68 in the validation cohort, while the Full model attained significantly higher performance, with AUCs of 0.80 (95% CI: 0.69–0.9) and 0.78, respectively. The Full model’s superior performance underscores the prognostic value of early laboratory trends, suggesting that dynamic data integration improves risk stratification. Both models outperformed existing risk scores across multiple metrics, provided well-calibrated probabilistic predictions, and demonstrated robustness to missing data. Additionally, they offered patient-level explainability, enhancing clinical interpretability. While promising, the models’ generalizability may be influenced by differences between the CULPRIT-SHOCK and eICU cohorts (e.g., demographics, CS severity thresholds); further validation in larger, prospective cohorts is warranted.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01927549
Funding Statement
This work was supported by the MODS project funded from the program "Profilbildung 2020" (grant no. PROFILNRW-2020-107-A), an initiative of the Ministry of Culture and Science of the State of Northrhine Westphalia and by the Helmholtz Portfolio Theme Supercomputing and Modeling for the Human Brain. The CULPRIT-SHOCK study was supported by a grant (FP7/2007-2013) from the European Union 7th Framework Program and by the German Heart Research Foundation and the German Cardiac Society.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used openly available human data that were originally located at: https://physionet.org/content/eicu-crd/2.0/ The study used upon-request human data that corresponded to the Clinical Trial: Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock [CULPRIT-SHOCK]; NCT01927549 https://clinicaltrials.gov/study/NCT01927549. Data requested from Holger Thiele, Heart Center Leipzig - University Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
For the CULPRIT-SHOCK, no personally identifiable information was used and individual participant data are not available for sharing. For the eICU dataset, data is publicly available at https://physionet.org/content/eicu-crd/2.0/ after registration.
